期刊文献+

布拉氏酵母菌散剂预防小儿抗生素相关性腹泻的效果观察 被引量:5

Effect observation of Saccharomyces boulardii sachets in the prevention of infantile antibiotic-associated diarrhea
下载PDF
导出
摘要 目的研究布拉氏酵母菌散剂预防小儿抗生素相关性腹泻的临床效果。方法本次研究选取的研究对象为2015年4月至2016年4月在我院进行治疗的200例肺炎患儿,将患儿随机分为对照组(抗生素治疗)和观察组(抗生素+布拉氏酵母菌散剂治疗),各100例。对比两组患儿的临床治疗效果。结果观察组患儿的抗生素使用时间长于对照组,腹泻持续时间、腹泻治愈时间短于对照组(P<0.05)。观察组患儿的每日大便次数少于对照组,大便性状评分高于对照组(P<0.05)。观察组肺炎患儿的腹泻程度和腹泻发生率均优于对照组(P<0.05)。结论布拉氏酵母菌散剂在预防小儿抗生素相关性腹泻发生上的效果确切,具有较高的临床推广价值。 Objective To study the effect of Saccharomyces boulardii sachets in the prevention of infantile antibiotic- associated diarrhea. Methods From April 2015 to April 2016, 200 children with pneumonia in our hospital were enrolled as the study objects, and randomly divided into control group (antibiotic treatment) and observation group (antibiotic + Saccharomyces boulardii sachets treatment), with 100 cases in each group. The treatment effects were compared in the two groups. Results The pneumonia antibiotic using time in the observation group was longer than that of the control group, diarrhea duration time and diarrhea cure time in the observation group were shorter than those in the control group (P〈0.05). The daily stool frequency in the observation group was lower than that in the control group, and the stool score was higher than that in the control group (P〈0.05). The severity of diarrhea and the incidence of diarrhea in the observation group were better than those in the control group (P〈0.05). Conclusion Saccharomyces boulardii sachets has good effect in the prevention of infantile antibiotic-associated diarrhea, which has high clinical promotion value.
作者 高金红
机构地区 三原县医院
出处 《临床医学研究与实践》 2017年第28期77-78,共2页 Clinical Research and Practice
关键词 抗生素相关性腹泻 小儿 布拉氏酵母菌散剂 antibiotic-associated diarrhea children Saccharomyces boulardii sachets
  • 相关文献

参考文献8

二级参考文献72

  • 1吴玉霞.布拉氏酵母菌散剂预防抗生素相关性腹泻的临床疗效观察[J].继续医学教育,2012,26(4):46-48. 被引量:10
  • 2朱军,刘建化,王凌云,王连源.抗生素相关性伪膜性肠炎的诊断和治疗[J].南方医科大学学报,2007,27(4):556-557. 被引量:40
  • 3薛辛东.儿科学[M].北京:人民卫生出版社,2010:271.
  • 4胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 5Mcfarland LV. Antibiotic-associated diarrhea: epidemiology, trends and treatment. Future Microbio1,2008,3 ( 5 ) : 563 -578.
  • 6Mcfarland LV. Meta-analysis of probiotics for the prevention of anti- biotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroentero1,2006,101 (4) : 812-822.
  • 7Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Sac- charomyces boulardii in the prevention of antibiotic-associated diar- rhoea. Aliment Pharmacol Ther, 2005,22 ( 5 ) : 365 -372.
  • 8D'Souza AL, Rajkumar C, Cooke J, et al. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ, 2002, 324 (7350) :1361.
  • 9Collignon A,Sandre C, Barc MC. Saccharomyces boulardii modu- lates dendritic cell properties and intestinal microbiota disruption after antibiotic treatment. Gastroenterol Clin Biol, 2010,34 ( Suppl 1 ) : $71-78.
  • 10Vandenplas Y, Brunser O, Szajewska H. Saccharomyces boulardii in childhood. Eur J Pediatr ,2009,168 (3) :253-265.

共引文献100

同被引文献32

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部